Adaptimmune Therapeutics PLC
ADAPYOTCCIK 1621227HealthcareFiscal year ends Dec 31
Reports and events: 279 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-10-2007:50 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-100618 |
| 2025-09-2616:30 ET | 8-K | 3.01 Delisting notice | 0001104659-25-093882 |
| 2025-09-1216:27 ET | 8-K | 3.01 Delisting notice | 0001104659-25-089558 |
| 2025-09-0816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-25-011925 |
| 2025-08-2916:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-25-011820 |
| 2025-08-1918:53 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001072613-25-000670 |
| 2025-08-1516:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-25-011616 |
| 2025-08-1416:31 ET | 8-K | 3.01 Delisting notice | 0001558370-25-011579 |
| 2025-08-1307:47 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011307 |
| 2025-08-1307:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011304 |
| 2025-08-0716:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-25-010785 |
| 2025-07-3117:02 ET | 8-K | 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-25-072753 |
| 2025-07-2807:37 ET | 8-K | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-071009 |
| 2025-07-1716:30 ET | 8-K | 8.01 Other events | 0001558370-25-009278 |
| 2025-05-2916:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-054232 |
| 2025-05-1316:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007571 |
| 2025-05-1307:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007493 |
| 2025-05-0116:15 ET | 8-K | 3.01 Delisting notice | 0001104659-25-043522 |
| 2025-04-2508:02 ET | DEF 14A | Proxy statementPeriod 2025-05-29 | 0001104659-25-039042 |
| 2025-04-1416:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-25-004768 |
| 2025-03-2416:44 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003544 |
| 2025-03-2416:40 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-25-003542 |
| 2025-03-2007:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-003340 |
| 2024-12-1907:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-016371 |
| 2024-11-1316:19 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015532 |
| 2024-11-1316:10 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001558370-24-015525 |
| 2024-11-1309:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-015446 |
| 2024-11-0117:00 ET | 8-K | 3.01 Delisting notice | 0001558370-24-014148 |
| 2024-09-2316:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-24-012960 |
| 2024-08-1207:23 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011798 |
| 2024-08-1207:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011793 |
| 2024-08-0207:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-085098 |
| 2024-07-1616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-009854 |
| 2024-06-1116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-009053 |
| 2024-05-3016:09 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-008778 |
| 2024-05-1516:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-008287 |
| 2024-05-1507:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-008210 |
| 2024-05-1507:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-008208 |
| 2024-05-1407:34 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-060884 |
| 2024-04-1208:05 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001558370-24-004997 |
| 2024-04-1108:00 ET | DEF 14A | Proxy statementPeriod 2024-05-14 | 0001104659-24-046093 |
| 2024-04-0220:38 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-24-000360 |
| 2024-03-0607:12 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-002537 |
| 2024-03-0607:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-002536 |
| 2024-02-2708:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-001756 |
| 2024-02-1616:05 ET | 8-K | 3.01 Delisting notice | 0001558370-24-001304 |
| 2024-01-3117:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-000672 |
| 2024-01-0407:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-000041 |
| 2023-12-0607:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-019493 |
| 2023-11-1407:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-018912 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.